Company · CIK 2056611

# Latigo Biotherapeutics, Inc.

| CIK | [2056611](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002056611) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | LTGO (Nasdaq) |
| First annual or quarterly report | 2026-09-03 |

## Offerings

 1 registration

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-297518 | IPO Final prospectus | 2026-07-17 | 2026-08-07 | 5 |

## Filings

 6

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-08-07 | [424B4](https://www.sec.gov/Archives/edgar/data/2056611/000119312526340329/0001193125-26-340329-index.htm) Final prospectus | 333-297518 | 0001193125-26-340329 |
| 2026-08-06 | [EFFECT](https://www.sec.gov/Archives/edgar/data/2056611/999999999526002566/9999999995-26-002566-index.htm) Declared effective | 333-297518 | 9999999995-26-002566 |
| 2026-08-04 | [S-1/A](https://www.sec.gov/Archives/edgar/data/2056611/000119312526331205/0001193125-26-331205-index.htm) Amendment | 333-297518 | 0001193125-26-331205 |
| 2026-08-03 | [S-1/A](https://www.sec.gov/Archives/edgar/data/2056611/000119312526329431/0001193125-26-329431-index.htm) Amendment | 333-297518 | 0001193125-26-329431 |
| 2026-07-17 | [S-1](https://www.sec.gov/Archives/edgar/data/2056611/000119312526307306/0001193125-26-307306-index.htm) Registration filed | 333-297518 | 0001193125-26-307306 |
| 2026-03-27 | [DRS](https://www.sec.gov/Archives/edgar/data/2056611/000119312526129261/0001193125-26-129261-index.htm) Draft made public | 377-09184 | 0001193125-26-129261 |

[All filings of this company](https://equitycapital.markets/filings?cik=2056611) · [CSV](https://equitycapital.markets/filings.csv?cik=2056611)

---
Source page: https://equitycapital.markets/company/2056611 · Data: U.S. SEC EDGAR · CC BY 4.0